These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15237852)

  • 21. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
    Tang W; Stearns RA
    Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric phenomena in cytochrome P450-catalyzed monooxygenations.
    Hlavica P; Lewis DF
    Eur J Biochem; 2001 Sep; 268(18):4817-32. PubMed ID: 11559350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?
    Davydov DR; Halpert JR
    Expert Opin Drug Metab Toxicol; 2008 Dec; 4(12):1523-35. PubMed ID: 19040328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Energetics of heterotropic cooperativity between alpha-naphthoflavone and testosterone binding to CYP3A4.
    Roberts AG; Atkins WM
    Arch Biochem Biophys; 2007 Jul; 463(1):89-101. PubMed ID: 17459328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme kinetics of cytochrome P450-mediated reactions.
    Shou M; Lin Y; Lu P; Tang C; Mei Q; Cui D; Tang W; Ngui JS; Lin CC; Singh R; Wong BK; Yergey JA; Lin JH; Pearson PG; Baillie TA; Rodrigues AD; Rushmore TH
    Curr Drug Metab; 2001 Mar; 2(1):17-36. PubMed ID: 11465149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites.
    Korzekwa KR; Krishnamachary N; Shou M; Ogai A; Parise RA; Rettie AE; Gonzalez FJ; Tracy TS
    Biochemistry; 1998 Mar; 37(12):4137-47. PubMed ID: 9521735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of cytochrome P450s with their ligands.
    Conner KP; Woods CM; Atkins WM
    Arch Biochem Biophys; 2011 Mar; 507(1):56-65. PubMed ID: 20939998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling atypical CYP3A4 kinetics: principles and pragmatism.
    Houston JB; Galetin A
    Arch Biochem Biophys; 2005 Jan; 433(2):351-60. PubMed ID: 15581591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition and induction of cytochrome P450 and the clinical implications.
    Lin JH; Lu AY
    Clin Pharmacokinet; 1998 Nov; 35(5):361-90. PubMed ID: 9839089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular modeling of human cytochrome P450-substrate interactions.
    Lewis DF
    Drug Metab Rev; 2002; 34(1-2):55-67. PubMed ID: 11996012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nile Red is a fluorescent allosteric substrate of cytochrome P450 3A4.
    Lampe JN; Fernandez C; Nath A; Atkins WM
    Biochemistry; 2008 Jan; 47(2):509-16. PubMed ID: 18092806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational identification and binding analysis of orphan human cytochrome P450 4X1 enzyme with substrates.
    Kumar S
    BMC Res Notes; 2015 Jan; 8():9. PubMed ID: 25595103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atypical cytochrome p450 kinetics: implications for drug discovery.
    Tracy TS
    Drugs R D; 2006; 7(6):349-63. PubMed ID: 17073518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.
    Cupp-Vickery J; Anderson R; Hatziris Z
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3050-5. PubMed ID: 10716705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.
    Houston JB; Kenworthy KE
    Drug Metab Dispos; 2000 Mar; 28(3):246-54. PubMed ID: 10681367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.
    Lin Y; Lu P; Tang C; Mei Q; Sandig G; Rodrigues AD; Rushmore TH; Shou M
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):368-74. PubMed ID: 11259318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance study of the structure and functions of cytochrome P450.
    Weiner LM
    CRC Crit Rev Biochem; 1986; 20(2):139-200. PubMed ID: 3011356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperative properties of cytochromes P450.
    Denisov IG; Frank DJ; Sligar SG
    Pharmacol Ther; 2009 Nov; 124(2):151-67. PubMed ID: 19555717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.